Aug 5 (Reuters) - Johnson & Johnson JNJ.N :
* JOHNSON & JOHNSON ANNOUNCES AGREEMENT WITH U.S. GOVERNMENT FOR 100 MILLION DOSES OF INVESTIGATIONAL COVID-19 VACCINE
* J&J - BARDA IN COLLABORATION WITH U.S. DEPARTMENT OF DEFENSE, IS COMMITTING OVER $1 BILLION FOR AGREEMENT
* J&J - VACCINE WILL BE PROVIDED AT A GLOBAL NOT-FOR-PROFIT BASIS FOR EMERGENCY PANDEMIC USE
* J&J - EVALUATING ONE- AND TWO-DOSE REGIMENS FOR COVID-19 VACCINE IN ITS CLINICAL PROGRAM
* J&J - U.S. GOVERNMENT MAY ALSO PURCHASE AN ADDITIONAL 200 MILLION DOSES OF AD26.COV2.S UNDER A SUBSEQUENT AGREEMENT
* J&J - AIMS TO MEET ITS GOAL TO SUPPLY MORE THAN ONE BILLION DOSES GLOBALLY THROUGH COURSE OF 2021, PROVIDED VACCINE IS SAFE AND EFFECTIVE